JAMA Internal Medicine

August 7, 2023

Effective medications for opioid use disorder rarely used

Vanderbilt research shows that most individuals diagnosed with opioid use disorder are not on recommended medications and even fewer remain in care.

By Craig Boerner
April 3, 2023

More U.S. prostate cancer patients choosing active surveillance

A Vanderbilt study found the number of prostate cancer patients in the U.S. choosing active surveillance over surgery or radiation has rapidly increased since 2010, rising from 16% to 60% for low-risk patients and from 8% to 22% for patients with favorable intermediate-risk cancers.

By Craig Boerner
Research by Mingjian Shi, PhD, left, Jonathan Mosley, MD, PhD, Kerry Schaffer, MD, MSCI, and colleagues found that polygenic risk score does not improve prediction of aggressive prostate cancer.
March 16, 2023

Study evaluates polygenic risk score for prostate cancer risk prediction

A Vanderbilt study found that prostate cancer polygenic risk score has limited utility for enhancing prostate cancer screening.

By Leigh MacMillan
(iStock)
February 6, 2023

VUMC’s ‘Shed-MEDS’ protocol can reduce risk of drug interactions in older people

Vanderbilt University Medical Center’s ‘Shed-MEDS’ protocol may reduce risk drug-drug interactions in older peole.

By Bill Snyder
June 28, 2022

Smokers have better quit rates with hospital-based interventions than quitline help, but study indicates need for longer follow-up

A health care system model that offered tobacco cessation treatment to smokers being discharged from a hospital produced a higher rate of tobacco abstinence during the three-month program than referral to a state-based telephone quitline, but the advantage disappeared at six months when both treatments produced comparable quit rates, researchers have found.

By Tom Wilemon
Adriana Hung, MD, MPH, talks with patient Sylvester Norman, who is participating in the VA Department’s Million Veteran Program.
February 10, 2022

Gene variants increase risk of kidney failure in veterans of African ancestry with COVID-19: study

Gene variants increased the risk of acute kidney injury and death in veterans of African ancestry who were hospitalized with COVID-19, possibly explaining some health disparities associated with COVID-19.

By Leigh MacMillan
December 16, 2021

Two VUMC papers named among genomic medicine’s top 10

Vanderbilt researchers wrote two of the “top 10” papers representing key advances in genomic medicine published between September 2020 and August 2021.
By Bill Snyder
July 26, 2021

Allergic reaction to first dose of an mRNA COVID-19 vaccine should not keep people from getting the second dose: study

An immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine — those manufactured by Moderna and Pfizer BioNTech — should not keep people from getting the second dose, a multi-hospital analysis shows.
By Nancy Humphrey
January 28, 2020

Protein levels in urine after acute kidney injury predict future loss of kidney function

High levels of protein in a patient’s urine after acute kidney injury is associated with increased risk of kidney disease progression, Vanderbilt researchers report.
By Kelsey Herbers
June 27, 2016

Large-Scale Study Finds Higher Rates of Severe Psychological Distress and Impaired Physical Health among LGBT Populations

In one of the largest, most representative health surveys conducted to date, lesbian, gay and bisexual adults reported substantially higher rates of severe psychological distress, heavy drinking and smoking, and impaired physical health than did heterosexuals.
By Craig Boerner
March 2, 2015

VU study finds peanut consumption associated with decreased total mortality and mortality from cardiovascular diseases

If you’re looking for a simple way to lower your risk of dying from a heart attack, consider going nuts.
By Kathy Whitney
January 20, 2015

Vanderbilt study finds use of methadone to treat pain carries increased risk of death

Outside the hospital, use of methadone to treat pain carries a 46 percent increased risk of death when compared to the equally effective but more costly alternative, morphine SR (sustained release).
By Paul Govern